JP2023520794A5 - - Google Patents

Info

Publication number
JP2023520794A5
JP2023520794A5 JP2022560311A JP2022560311A JP2023520794A5 JP 2023520794 A5 JP2023520794 A5 JP 2023520794A5 JP 2022560311 A JP2022560311 A JP 2022560311A JP 2022560311 A JP2022560311 A JP 2022560311A JP 2023520794 A5 JP2023520794 A5 JP 2023520794A5
Authority
JP
Japan
Prior art keywords
compound
propa
tetrahydro
biphenyl
diol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022560311A
Other languages
English (en)
Japanese (ja)
Other versions
JP7714571B2 (ja
JP2023520794A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2021/050812 external-priority patent/WO2021198692A1/en
Publication of JP2023520794A publication Critical patent/JP2023520794A/ja
Publication of JP2023520794A5 publication Critical patent/JP2023520794A5/ja
Application granted granted Critical
Publication of JP7714571B2 publication Critical patent/JP7714571B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022560311A 2020-03-31 2021-03-31 テルペンフェノール化合物およびそれらの使用 Active JP7714571B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063003270P 2020-03-31 2020-03-31
US63/003,270 2020-03-31
PCT/GB2021/050812 WO2021198692A1 (en) 2020-03-31 2021-03-31 Terpenophenolic compounds and their use

Publications (3)

Publication Number Publication Date
JP2023520794A JP2023520794A (ja) 2023-05-19
JP2023520794A5 true JP2023520794A5 (https=) 2024-04-11
JP7714571B2 JP7714571B2 (ja) 2025-07-29

Family

ID=75426633

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022560311A Active JP7714571B2 (ja) 2020-03-31 2021-03-31 テルペンフェノール化合物およびそれらの使用

Country Status (12)

Country Link
US (2) US12552733B2 (https=)
EP (1) EP4126800A1 (https=)
JP (1) JP7714571B2 (https=)
KR (1) KR20230121960A (https=)
CN (1) CN116194431B (https=)
AU (1) AU2021248627A1 (https=)
BR (1) BR112022019616A2 (https=)
CA (1) CA3177186A1 (https=)
GB (2) GB2609814B (https=)
IL (1) IL296861A (https=)
MX (1) MX2022011832A (https=)
WO (1) WO2021198692A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3179235A1 (en) * 2019-05-23 2020-11-26 Kare Chemical Technologies Inc. Catalytic cannabinoid processes and precursors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136839A (en) * 2000-06-16 2006-12-10 Yissum Res Dev Co Pharmaceutical compositions comprising cannabidiol derivatives, and processes for the preparation of same
CA2623723A1 (en) 2005-09-29 2007-04-12 Amr Technology, Inc. Process for production of delta-9-tetrahydrocannabinol
DK2176208T3 (en) * 2007-07-30 2015-04-27 Zynerba Pharmaceuticals Inc Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
TWI583374B (zh) * 2010-03-30 2017-05-21 Gw伐瑪有限公司 使用植物大麻素次大麻二酚(cbdv)來治療癲癇之用途
WO2014177593A1 (en) 2013-04-29 2014-11-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Amorfrutin analogs as ppargamma-modulators
US9526706B1 (en) 2015-06-16 2016-12-27 Hong Kong Baptist University Method of using dihydro-resveratrol for treating acute pancreatitis and associated pulmonary injury
US9738581B2 (en) * 2015-06-16 2017-08-22 Hong Kong Baptist University Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions
US10059683B2 (en) 2015-07-10 2018-08-28 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
AU2017250303B2 (en) 2016-04-15 2019-09-26 Teewinot Technologies Limited Biosynthesis of cannabinoid prodrugs
JP2019523228A (ja) 2016-06-16 2019-08-22 ティーウィノット テクノロジーズ リミテッド カンナビノイドプロドラッグの製造のための方法、薬学的製剤、およびその使用
US10640482B2 (en) 2017-07-21 2020-05-05 University Of South Florida Synthesis of cannabinoids
SG11202001725SA (en) * 2017-09-01 2020-03-30 Pureform Global Inc Synthetic cannabidiol compositions and methods of making the same
JP2021535203A (ja) * 2018-08-20 2021-12-16 ベッソール ファルマ、エルエルシー 既知および新規カンナビノイドの適用
CA3179235A1 (en) * 2019-05-23 2020-11-26 Kare Chemical Technologies Inc. Catalytic cannabinoid processes and precursors
AU2020345656A1 (en) * 2019-09-09 2022-04-21 Kare Chemical Technologies Inc. Cannabinoid derivatives, precursors and uses
WO2021046640A1 (en) * 2019-09-10 2021-03-18 Kare Chemical Technologies Inc. Cannabinoid derivatives and precursors, and asymmetric synthesis for same

Similar Documents

Publication Publication Date Title
TWI335217B (en) Pharmaceutical formulations of modafinil
Liu et al. Synthetic approaches to the 2009 new drugs
AU2020239746B2 (en) Compositions comprising methylphenidate-prodrugs, processes of making and using the same
JP2006522747A5 (https=)
JP2002523452A (ja) 肺疾患の治療方法
CN102159077A (zh) 用于治疗神经性疼痛的方法
US12128012B2 (en) Ketamine treatment for amyotrophic lateral sclerosis
MX2010013312A (es) Tratamientos novedoos.
JP2023520794A5 (https=)
CN102307836B (zh) 用于治疗疼痛的化合物
JP2005531612A (ja) ネフォパムの製剤および痛みの治療におけるその使用
CA2422901A1 (en) Use of tolterodine to treat asthma
EP1096931A2 (en) Use of (s) (-)-amisulpride for the manufacture of a medicament for the treatment of schizophrenia
GB2609814A (en) Terpenophenolic compounds and their use
JP2001511158A (ja) 不穏下肢症候群の治療におけるプラミペキソールの使用
CN101507726B (zh) 窦房结If电流抑制剂和β-阻滞剂的组合
US6194466B1 (en) Use of metformin to counteract weight gain associated with valproate and other psychotropic medications
JP2022518288A5 (https=)
JP2004002474A (ja) 純粋なフルオキセチンのs(+)異性体を用いる組成物
US20240226110A1 (en) 5-ht2c agonist for use in treating conditions associated with central hypoventilation
CN114080221B (zh) 用于减轻疼痛的布洛芬与曲马多的组合
CN115252583B (zh) 复方盐酸替利定缓释制剂及其制备方法
JP4888751B2 (ja) トリフルオロプロピルアミノペンタン誘導体及びその製造方法
JPH10338634A (ja) 医薬組成物
JP2004538305A (ja) 3−ヘテロシクリル−及び3−シクロアルキル−3−アリールオキシプロパンアミンによる慢性疼痛の治療